Liron Walsh
Overview
Explore the profile of Liron Walsh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
646
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fontana M, Solomon S, Kachadourian J, Walsh L, Rocha R, Lebwohl D, et al.
N Engl J Med
. 2024 Nov;
391(23):2231-2241.
PMID: 39555828
Background: Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) is a progressive, often fatal disease. Nexiguran ziclumeran (nex-z) is an investigational therapy based on CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats and associated...
2.
Mariani L, Trachtman H, Thompson A, Gillespie B, Denburg M, Diva U, et al.
Am J Kidney Dis
. 2024 Oct;
PMID: 39455047
Focal segmental glomerulosclerosis (FSGS) is a characteristic histopathological lesion that is indicative of underlying glomerular dysfunction. It is not a single disease entity but rather a heterogeneous disorder that is...
3.
Gipson D, Pal M, Desmond H, Anderson C, Walsh L, Trachtman H, et al.
Glomerular Dis
. 2023 Oct;
3(1):132-139.
PMID: 37901701
Introduction: Edema is a common manifestation of proteinuric kidney diseases, but there is no consensus approach for reliably evaluating edema. The objective of this study was to develop an edema...
4.
Walsh L, Reilly J, Cornwall C, Gaich G, Gipson D, Heerspink H, et al.
Kidney Int Rep
. 2021 Oct;
6(10):2575-2584.
PMID: 34622097
Introduction: A critical unmet need exists for precision therapies for chronic kidney disease. GFB-887 is a podocyte-targeting, small molecule inhibitor of transient receptor potential canonical-5 (TRPC5) designed specifically to treat...
5.
Carlozzi N, Massengill S, Trachtman H, Walsh L, Singhal N, LaVigne J, et al.
Kidney Med
. 2021 Aug;
3(4):484-497.e1.
PMID: 34401716
Rationale & Objective: Assessment of how patients feel and function is needed for clinical care and research for focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD). The objective of...
6.
Troost J, Trachtman H, Spino C, Kaskel F, Friedman A, Moxey-Mims M, et al.
Am J Kidney Dis
. 2020 Aug;
77(2):216-225.
PMID: 32791086
Rationale & Objective: Remission of proteinuria has been shown to be associated with lower rates of kidney disease progression among people with focal segmental glomerulosclerosis (FSGS). The goal of this...
7.
Rangarajan S, Walsh L, Lester W, Perry D, Madan B, Laffan M, et al.
N Engl J Med
. 2017 Dec;
377(26):2519-2530.
PMID: 29224506
Background: Patients with hemophilia A rely on exogenous factor VIII to prevent bleeding in joints, soft tissue, and the central nervous system. Although successful gene transfer has been reported in...
8.
A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease
Byrne B, Geberhiwot T, Barshop B, Barohn R, Hughes D, Bratkovic D, et al.
Orphanet J Rare Dis
. 2017 Aug;
12(1):144.
PMID: 28838325
Background: Late-onset Pompe disease is a rare genetic neuromuscular disorder caused by lysosomal acid alpha-glucosidase (GAA) deficiency that ultimately results in mobility loss and respiratory failure. Current enzyme replacement therapy...
9.
Block G, Bushinsky D, Cunningham J, Drueke T, Ketteler M, Kewalramani R, et al.
JAMA
. 2017 Jan;
317(2):146-155.
PMID: 28097355
Importance: Secondary hyperparathyroidism contributes to extraskeletal complications in chronic kidney disease. Objective: To evaluate the effect of the intravenous calcimimetic etelcalcetide on serum parathyroid hormone (PTH) concentrations in patients receiving...
10.
Walsh L, Dinavahi R
Front Biosci (Elite Ed)
. 2015 Dec;
8(1):1-14.
PMID: 26709641
While has been considerable progress in the short-term outcomes following renal transplantation over the last several decades, minimal gains have been made with regards to long-term graft function and patient...